ND Expert Sean Kassen: Statement on first FDA-approved treatment for Niemann-Pick Type C disease
Today, the FDA announced the first approved treatment for Niemann-Pick Type C (NPC) disease: an oral medication named Miplyffa (arimoclomol). Sean Kassen, director of the Ara Parseghian Medical Research Fund at the University of Notre Dame, said this represents the beginning of a new and hopeful era for NPC families.
“It has been almost 30 years to the day since Michael, Marcia and Christa Parseghian were diagnosed with Niemann-Pick Type C disease, eventually taking their young lives. Since that time the Parseghian family and so many other families, researchers and volunteers have worked tirelessly to advance our understanding of NPC and bring treatments to those affected by this devastating disease. Today marks a momentous occasion with the FDA approval of Miplyffa and the start of a new era with the first official medication for the treatment of NPC disease. We will continue to fight for NPC families until this disease is eradicated,” Kassen said.
The APMRF is a non-profit organization dedicated to finding a treatment or cure for Niemann-Pick Type C disease. The organization is named in honor of Ara Parseghian, the much beloved and well-known Notre Dame football coach, and was founded by Mike and Cindy Parseghian, whose three children — Michael, Marcia and Christa — were diagnosed with NPC in 1994.
Latest ND NewsWire
- To prevent opioid misuse in teens and young adults, researchers turn to AI and social media dataResearchers at Notre Dame are developing a new artificial intelligence-driven paradigm built on social media data to provide insights into personalized interventions for reducing opioid misuse and death among teens and young adults.
- Notre Dame receives significant gift from the Ernestine Morris Carmichael Raclin estateThe Raclin Murphy Museum of Art at the University of Notre Dame is the beneficiary of a significant gift of paintings, sculptures, and decorative art objects from the estate of Ernestine Morris Carmichael Raclin.
- Firms that withdrew from Russia following Ukraine invasion earn higher consumer sentimentCorporate decisions to withdraw from Russia during the Ukraine war positively impacted consumer sentiment, especially for companies with strong ESG reputations, according to new research from Shankar Ganesan, Notre Dame's Raymond W. and Kenneth G. Herrick Collegiate Professor of Marketing.
- Notre Dame juniors Faiza Filali, Angela Olvera named Obama-Chesky Voyager ScholarsUniversity of Notre Dame juniors Faiza Filali and Angela Olvera have been named to the third cohort of Obama-Chesky Voyager Scholars. They are Notre Dame’s second and third Voyager Scholars after senior Raleigh Kuipers, who recently returned from Latin America as a member of the second cohort.
- Notre Dame theologian to receive 2024 Ratzinger Prize from VaticanCyril O’Regan, the Catherine F. Huisking Professor of Theology at the University of Notre Dame, has been selected to receive the 2024 Ratzinger Prize in Theology, widely regarded as the most prestigious award in the field. Pietro Parolin, the Vatican’s secretary of state, will present the award to O’Regan and to sculptor Etsurō Sotoo during a ceremony at the Apostolic Palace in Vatican City on Nov. 22. Both winners will also have an audience with Pope Francis earlier that day.
- Keough School invites members of the community to join in International Day of Peace eventsThe Keough School of Global Affairs will observe the International Day of Peace with two campus events: a prayer service featuring University President Rev. Robert A. Dowd, C.S.C., on Friday (Sept. 20) and a talk by a Notre Dame graduate who serves in the Sierra Leone government on Tuesday (Sept. 24). Both events are free and open to the public.